Back to calendar
Kyverna Therapeutics, Inc. (KYTX) Earnings
KYTX reports earnings on Wednesday, November 18, 2026
earnings report
November 18, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.69
Actual EPS: $-0.63
EPS surprise: 7.13%
Company overview
Market Cap$351.3M
PriceUSD 5.68
EPS (TTM)-2.94
52-week high13.67
52-week low5.16
SectorHealth Technology
IndustryBiotechnology
Employees130